Chemed (NYSE:CHE) Issues FY24 Earnings Guidance

Chemed (NYSE:CHEGet Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $23.55-23.80 for the period, compared to the consensus EPS estimate of $23.21. Chemed also updated its FY 2024 guidance to 23.550-23.800 EPS.

Chemed Stock Performance

Shares of NYSE:CHE traded up $9.18 during midday trading on Friday, reaching $550.15. The company’s stock had a trading volume of 53,102 shares, compared to its average volume of 85,127. The firm has a market capitalization of $8.33 billion, a price-to-earnings ratio of 29.50, a PEG ratio of 2.25 and a beta of 0.43. The firm has a 50 day moving average price of $543.57 and a two-hundred day moving average price of $583.29. Chemed has a fifty-two week low of $492.84 and a fifty-two week high of $654.62.

Chemed (NYSE:CHEGet Free Report) last issued its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing analysts’ consensus estimates of $5.59 by ($0.12). Chemed had a net margin of 12.88% and a return on equity of 29.90%. The firm had revenue of $595.88 million during the quarter, compared to the consensus estimate of $599.20 million. During the same period in the previous year, the firm earned $4.71 earnings per share. The business’s quarterly revenue was up 7.6% on a year-over-year basis. As a group, research analysts anticipate that Chemed will post 21.54 earnings per share for the current year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Thursday, May 30th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 0.29%. The ex-dividend date was Thursday, May 30th. Chemed’s payout ratio is 8.61%.

Wall Street Analysts Forecast Growth

CHE has been the subject of a number of research analyst reports. Royal Bank of Canada decreased their target price on Chemed from $712.00 to $697.00 and set an outperform rating for the company in a research report on Tuesday, May 21st. StockNews.com raised Chemed from a hold rating to a buy rating in a research report on Saturday, May 4th.

Read Our Latest Research Report on Chemed

Insiders Place Their Bets

In other Chemed news, Director Patrick P. Grace sold 284 shares of the business’s stock in a transaction that occurred on Wednesday, June 12th. The stock was sold at an average price of $540.98, for a total transaction of $153,638.32. Following the completion of the sale, the director now directly owns 3,270 shares of the company’s stock, valued at approximately $1,769,004.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, CEO Kevin J. Mcnamara sold 4,000 shares of the company’s stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $567.54, for a total value of $2,270,160.00. Following the completion of the transaction, the chief executive officer now directly owns 108,549 shares of the company’s stock, valued at $61,605,899.46. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Patrick P. Grace sold 284 shares of the company’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the transaction, the director now directly owns 3,270 shares of the company’s stock, valued at $1,769,004.60. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,784 shares of company stock valued at $3,240,053. Corporate insiders own 3.32% of the company’s stock.

Chemed Company Profile

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Featured Stories

Earnings History and Estimates for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.